Methods of treating cutaneous lupus erythematosus and systemic lupus erythematosus

MYPI2026002918A0Undetermined Publication Date: 2022-06-03BIOGEN MA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026002918
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-03
Filing Date
2021-12-03
Publication Date
2022-06-03
Patent Text Reader

Abstract

Dosage regimens of anti-Blood Dendritic Cell Antigen 2 antibodies are provided for use in the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus. Figure 1.
Need to check novelty before this filing date? Find Prior Art